Welcome to our dedicated page for KONTROL TECHNOLOGIES news (Ticker: KNRLF), a resource for investors and traders seeking the latest updates and insights on KONTROL TECHNOLOGIES stock.
Kontrol Technologies Corp (KNRLF) is a leading provider of smart energy management solutions for a sustainable future. The company specializes in IoT technology, energy efficiency, and emission reduction. With a focus on innovation and environmental stewardship, Kontrol Technologies is revolutionizing the way businesses and organizations manage their energy consumption. Their cutting-edge solutions help clients optimize energy usage, reduce costs, and minimize their carbon footprint.
Through strategic partnerships and a commitment to research and development, Kontrol Technologies is at the forefront of the green technology revolution. The company's products and services are designed to help customers achieve energy savings, improve operational efficiency, and meet sustainability goals. Kontrol Technologies is dedicated to creating a cleaner, greener planet for future generations.
Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF) has secured approval from 67.06% of debenture holders to extend the maturity of the "8% Unsecured Redeemable Debentures Due October 31, 2020" to December 15, 2020. This decision coincides with a non-brokered private placement, generating $5,800,000 in gross proceeds. The new debentures, maturing October 31, 2022, will continue to accrue interest at 8% annually. Kontrol Energy focuses on energy efficiency solutions through technology, aiming to lower energy costs and GHG emissions.
Kontrol Energy Corp. provides an update on its BioCloud technology, achieving a lower detection limit of 50 SARS-CoV-2 virus particles, crucial for commercialization. The company plans to produce BioCloud units in November and seeks certifications (CSA, CE, UL) for market compliance. As of October 28, 2020, Kontrol has approximately $3 million in cash to support this initiative. The BioCloud technology aims to enhance safety in public spaces by detecting airborne viruses.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) has been ranked 81st in the Globe and Mail's Top Growing Companies list for 2020. The company secured a new order for its SmartSuite technology across four apartment buildings in Ontario, enhancing energy management. Additionally, Kontrol has initiated a name change to Kontrol Technologies Inc. to better represent its focus on smart technology solutions. The company also received funding for its BioCloud analyzer, a real-time virus detection system, aimed at improving safety in various environments.
Kontrol Energy Corp. (OTCQB:KNRLF) has advanced to the commercialization phase of its BioCloud analyzer following successful pre-commercialization testing. The company anticipates launching BioCloud, designed for detecting airborne viruses in populated spaces, by November 2020. Kontrol is engaging with government entities for funding and establishing a supply chain capable of producing up to 20,000 units monthly. With a strengthened balance sheet from $1 Million in cash raised through share options, the company is positioned for growth in the health technology market.
Kontrol Energy Corp. has announced positive lab results for its Kontrol BioCloud technology, successfully testing against the live COVID-19 virus. Following previous tests on the dormant SARS-CoV-2 virus, the company is shifting its focus to commercialization, targeting CSA Group approval within 30 to 45 days. Kontrol aims for a manufacturing capacity of up to 20,000 units per month. This innovative technology is designed to monitor air quality and detect airborne viruses in various public settings, although no claims are made regarding its effectiveness against COVID-19.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) has engaged sagecomm, a marketing communications firm, to promote its Kontrol BioCloud technology. This real-time analyzer detects airborne viruses and is intended for various communal settings. CEO Paul Ghezzi stated that the timing is right to broaden the BioCloud narrative. Despite the positive sentiment, the company has not made claims about the product's efficacy against COVID-19. Kontrol has a history of growth, being recognized as one of Canada's fastest-growing firms in recent years.
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) has provided an update on its Kontrol BioCloud technology, a real-time analyzer aimed at detecting airborne viruses, including COVID-19. Lab testing since August 31, 2020, shows consistent positive results with its prototype. Live COVID-19 testing is rescheduled for September 8, 2020, and five functioning BioCloud units are expected soon. The technology targets areas with high foot traffic and is positioned for commercialization, although the company does not claim to eliminate or cure COVID-19.
Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF) announced its financial results for the six months ending June 30, 2020. The company reported Q2 revenue of $2.27M, down from $3.91M in Q2 2019, with a net loss of $437K. Despite challenges from COVID-19, Kontrol maintained positive EBITDA and cash flow. The acquisition of New Found Air aims to expand its customer base. Kontrol is also advancing its BioCloud technology for COVID-19 detection, with aims for commercial availability in 2020.
The company’s cash position stands at approximately $1.8M.
Kontrol Energy Corp. (OTCQB: KNRLF) has announced it will release its Q2 2020 financial results on August 31, 2020, at 4:30 PM ET. The call will be led by CEO Paul Ghezzi and CFO Claudio Del Vasto and will last 60 minutes. This release marks an important update for investors as the company is focused on energy efficiency through IoT, Cloud, and SaaS technologies. Kontrol aims to reduce energy costs and greenhouse gas emissions for its clients, highlighting its growth strategy and market positioning in the energy sector.
Kontrol Energy Corp. announced positive lab results for its Kontrol BioCloud technology, a prototype designed to detect airborne viruses, including COVID-19. The prototype showcased effective real-time detection capabilities during controlled tests, marking a significant milestone for the company. Kontrol plans to begin testing against live COVID-19 virus soon and aims for commercialization thereafter, with anticipated pricing around $12,000 per unit. The technology also exhibits potential for detecting other airborne viruses. Kontrol is self-funding its BioCloud development without external capital raises.